Skip to main content
OpenTrials

Clinical trial condition

Platinum-refractory Ovarian Cancer

Explore clinical trials studying Platinum-refractory Ovarian Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Platinum-refractory Ovarian Cancer trial results

Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Conditions
Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
Locations
  • The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
View all 32 locations
View Trial Details

Related conditions